Molecular Medicine is a multidisciplinary field at the intersection of biology, genetics, and medicine, aiming to understand the molecular mechanisms underlying disease and to develop targeted therapies based on this knowledge. By elucidating the molecular basis of diseases at the cellular and genetic levels, molecular medicine provides insights into disease pathology and enables the development of personalized treatment strategies. Advancements in molecular biology techniques, such as DNA sequencing, gene expression analysis, and genome editing technologies like CRISPR-Cas9, have revolutionized our understanding of disease mechanisms and paved the way for precision medicine approaches. Molecular diagnostics, including molecular profiling and genetic testing, allow for early disease detection and risk assessment, facilitating timely interventions and personalized treatment plans. In molecular medicine, researchers investigate the role of genes, proteins, and signaling pathways in health and disease, with the goal of identifying therapeutic targets and developing novel interventions. This includes the discovery of new drug targets, the development of targeted therapies, such as monoclonal antibodies and gene therapies, and the repurposing of existing drugs for new indications based on molecular insights.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico